Skip to main content
    I

    Immunitybio Inc (IBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.98
    -0.04 (-0.66%)

    Market Cap: $6.40B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Immunitybio Inc (IBRX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Immunitybio are Immunovant (IMVT), Iovance Biotherapeutics (IOVA) and Abivax SA American Depositary Shares (ABVX). By market cap, Immunitybio ranks 8th of the 13 companies on this page; Vaxcyte (PCVX) is the largest at $10.03B.

    Peer Comparison

    IBRX's ROIC of -780.5% is below the peer median of -43.4%, and its revenue growth of 52.3% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Immunitybio (IBRX)$6.40BN/A30.3x0.0%-780.5%52.3%0.00%
    Immunovant Inc (IMVT)$7.07BN/AN/A0.0%N/A0.0%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Abivax SA American Depositary Shares (ABVX)$7.67BN/AN/A0.0%-159.6%-6.8%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Vaxcyte Inc (PCVX)$10.03BN/AN/A0.0%N/A0.0%0.00%
    CG Oncology, Inc. Common stock (CGON)$6.65BN/AN/A0.0%-21.1%-3.7%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Dianthus Therapeutics Inc. (DNTH)$5.17BN/AN/A0.0%N/A205.6%0.00%
    Tango Therapeutics Inc (TNGX)$4.32BN/AN/A0.0%N/A-100.0%0.00%
    Peer median$6.86B176.8x10.1x0.0%-43.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Immunitybio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Immunovant Inc (IMVT)
    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
    IMVT competitors
    Iovance Biotherapeutics Inc (IOVA)
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Abivax SA American Depositary Shares (ABVX)
    Abivax SA is a clinical-stage biotechnology firm focused on pioneering immunotherapies for chronic inflammatory diseases and viral infections.
    ABVX competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Vaxcyte Inc (PCVX)
    Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally.
    PCVX competitors
    CG Oncology, Inc. Common stock (CGON)
    CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070...
    CGON competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    Dianthus Therapeutics Inc. (DNTH)
    Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops...
    DNTH competitors
    Tango Therapeutics Inc (TNGX)
    Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation...
    TNGX competitors

    Frequently Asked Questions About IBRX

    Who are Immunitybio's main competitors?

    The companies most similar to Immunitybio include Immunovant (IMVT), Iovance Biotherapeutics (IOVA), Abivax SA American Depositary Shares (ABVX), TG Therapeutics (TGTX) and Legend Biotech (LEGN), listed from the closest match.

    Who is Immunitybio's biggest competitor?

    Vaxcyte (PCVX) is the largest of the similar companies at $10.03B; Immunovant (IMVT) is the closest match by business profile, size, sector and industry.

    How does IBRX stock compare with its competitors?

    IBRX's P/S is 30.3x against a peer median of 10.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Immunitybio's competitors pays a higher dividend?

    Immunitybio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Immunitybio bigger than its competitors?

    No. Immunitybio is 8th by market cap among the 13 companies on this page; the largest is Vaxcyte (PCVX) at $10.03B.